简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Video
Research
HOME
·
CH BIOTECH SER
CH BIOTECH SER (08037.HK): Penbo (Hainan) BNCT hospital enters into cross-border oncology cooperation agreement with Hong Kong Oncare
Tags：
CH BIOTECH SER
08037.HK
strategic cooperation
2026-09-03
CH BIOTECH SER (08037.HK): Enters master cooperation agreement with Stella Pharma to develop and commercialize Steboronine®, world's first approved BNCT drug, in China
Tags：
CH BIOTECH SER
08037.HK
strategic cooperation
2026-08-12
CH BIOTECH SER (08037.HK) Announces Resignation of Executive Director He Xun
Tags：
CH BIOTECH SER
08037.HK
resignation
2026-04-30
Featured News
Finance
XUNCE (03317.HK): Signs memorandum of cooperation with GP Capital, to build AI-native portfolio ecosystem
Finance
EASY SMART GP (02442.HK): Issues profit warning, expects full-year loss to widen to not more than HKD 32 million
Finance
PALASINO (02536.HK): Independent non-executive director Jiao Jie resigns, ceases to be audit committee member
Finance
BQD (03866.HK): Completes Issue of 2026 First Tranche of Financial Bonds (Bond Connect) of RMB 4.5 Billion
Finance
HENGRUI PHARMA (01276.HK): Makes A-Share Repurchase of 335,000 Shares for RMB 14,503,550
Finance
CCIAM FUTURE EN (00145.HK): Change of Company Secretary — Huang Hongxin Succeeds Zeng Kunye
Finance
ESPRIT HOLDINGS (00330.HK): Receives Statutory Demand for Payment of USD 3,992,648.83 and HKD 41,656.36
Finance
MAXNERVA TECH (01037.HK): Appoints Ballas Capital as Independent Financial Adviser on Mandatory Conditional Cash Offer
Finance
FUYAO GLASS (03606.HK): Completes Issue of 2026 Fourth Tranche of Super Short-Term Commercial Paper of RMB 650 Million at 1.44%
Finance
LONGSYS (09976.HK): Guarantee Cap for Subsidiary Shanghai Longsys Storage Raised to RMB 1.4 Billion
Scan QR Code
Download App
